hotspot -WSS

hotspot

author：explore 2025-10-01 22:58:40 - browse：522

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A new crop of companies is reshaping the health data economy

explore

focus

WSS

Supreme Court strikes down use of affirmative action

The high cost of giving birth even with insurance

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

'Investigate these claims': UFO transparency at center of House hearing

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Anesthesiologist group: stop taking Ozempic before surgery

Wikipedia

hotspot

leisure time

Apple is now the first public company to be valued at $3 trillion

Anesthesiologist group: stop taking Ozempic before surgery

Affirmative action in medical school literally saved lives

Continuity nursing helped my family in our darkest PICU moments

Dobbs anniversary: the lost opportunity of abortion as health care

Will the FTC rein in IQVIA's health data empire?

The high cost of giving birth even with insurance

Truvian presents data for its desktop blood

BioMarin wins approval for gene therapy to treat hemophilia A

Alkermes shareholders re

explore

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Biden warns of ‘dark winter’ during final presidental debate

As demand for Covid shots wanes, Moderna seeks its next success

Rise in cancer among younger people worries and puzzles doctors

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

explore

hotspot

focus

hotspot